Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for Zai Lab (ZLAB) over the last 8 years, with Q3 2025 value amounting to $717.2 million.

  • Zai Lab's Cash & Equivalents rose 1640.5% to $717.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $717.2 million, marking a year-over-year increase of 1640.5%. This contributed to the annual value of $449.7 million for FY2024, which is 4309.1% down from last year.
  • Zai Lab's Cash & Equivalents amounted to $717.2 million in Q3 2025, which was up 1640.5% from $732.2 million recorded in Q2 2025.
  • Zai Lab's Cash & Equivalents' 5-year high stood at $1.8 billion during Q2 2021, with a 5-year trough of $449.7 million in Q4 2024.
  • Its 5-year average for Cash & Equivalents is $877.3 million, with a median of $790.2 million in 2023.
  • In the last 5 years, Zai Lab's Cash & Equivalents soared by 69514.78% in 2021 and then tumbled by 6146.1% in 2022.
  • Zai Lab's Cash & Equivalents (Quarter) stood at $964.1 million in 2021, then grew by 4.6% to $1.0 billion in 2022, then fell by 21.65% to $790.2 million in 2023, then plummeted by 43.09% to $449.7 million in 2024, then skyrocketed by 59.49% to $717.2 million in 2025.
  • Its Cash & Equivalents was $717.2 million in Q3 2025, compared to $732.2 million in Q2 2025 and $757.3 million in Q1 2025.